Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin Sensitisation:
In a Contact Dermal Sensitization Test - Buehler Method Test, the challenge sites of the test group with 100% topical induction dose had a score of one in 7 out of 20 animals (35%) at 24 hours and 3 out of 20 animals (15%) at 48 hours following patch removal, which is above 15%, the GHS criteria for skin sensitization. Based on the topical induction dose of 100% (> 20%), lithium nickel potassium oxide (KDLNO) is considered to be a Category 1B dermal sensitizer according to GHS Classification and Labeling of Chemicals.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Remarks:
- This study is designed to comply with the standards set forth in U.S. Environmental Protection Agency (EPA) Health Effects Test Guideline OCSPP 870.2600: Skin Sensitization, and The OECD Guideline for the Testing of Chemicals No. 406: Skin Sensitization.
- Type of information:
- experimental study
- Remarks:
- This study was initially designed to meet regulatory needs in North America. This study is designed to comply with the standards set forth in U.S. Environmental Protection Agency (EPA) Health Effects Test Guideline OCSPP 870.2600: Skin Sensitization
- Adequacy of study:
- key study
- Study period:
- Study Completed On
22 Oct 2019 - Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- OECD Guideline 406 is referenced in OCSPP 870.2600 as an acceptable method to assess the potential of a substance to promote skin sensitization reaction.
Contact Dermal Sensitization is an immunological process where the host animal, through repeated skin exposure, acquires a specific allergic sensitivity (reactivity) to a substance. In the Buehler guinea pig model, contact dermal sensitivity is manifested as increased erythema - Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male/female
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- Induction: Group 1, 100%: Ten males and 10 females were dosed with 0.4 g of the test article
(moistened with 0.1 ml of distilled water). The dose was applied to the left shoulder area using a 25-mm Hilltop Chamber® which is designed to keep the test article on a 25 mm area of the site. The chamber was covered with a strip of rubber dental dam sufficient to cover the treated sites. The torso was wrapped with non-irritating tape to provide occlusion. Six hours post-dosing, the dams and test article were removed. Any residual test article was cleansed from the sites with distilled water and the sites were dried with gauze or soft toweling. This procedure was performed once per week on the same day each week for a three week period, a total of three six-hour exposures.
Group 2: Five males and five females were untreated for the three-week induction period and
served as the naive control. - Day(s)/duration:
- This procedure was performed once per week on the same day each week for a three week period, a total of three six-hour exposures.
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- acetone/olive oil (4:l v/v)
- Concentration / amount:
- Challenge: Fourteen days after the last induction exposure, animals in Groups 1 and 2 were challenged using the same dosing procedure as in the induction phase. As specified in the protocol, 50% HCA in acetone was chosen as the highest non-irritating concentration for the challenge. The doses were applied to a naive site on the lower left dorsal area.
- Day(s)/duration:
- Fourteen days after the last induction exposure
- No. of animals per dose:
- Group 1: Ten males and 10 females were dosed with 0.4 g of the test article
(moistened with 0.1 ml of distilled water).
Group 2: Five males and five females were untreated for the three-week induction period and
served as the naive control. - Details on study design:
- EXPERIMENTAL DESIGN
Test Animals
Animals were received from Elm Hill Breeding Labs., Inc., Chelmsford, MA on 29 May 2019. Following an acclimation period of at least five days, fifteen healthy male and fifteen healthy female non-pregnant and nulliparous Hartley Albino guinea pigs were assigned to the study without conscious bias. The animals were born on 05 May 2019. The pre-test body weight range was 313 to 381 g for males and 311 to 370 g for females. All study animals gained body weight by study termination, which was considered to be similar to that expected for normal untreated animals of the same age and strain.The animals were identified by cage notation and a uniquely numbered metal ear tag and individually housed in suspended wire-bottom cages. Absorbent paper bedding was placed beneath the cages and changed at least three times per week. Fresh, Certified Guinea Pig LabDiet® No. 5026 and water were available ad libitum. The animal room, reserved exclusively for guinea pigs on acute tests, was temperature controlled, had a 12-hour light/dark cycle, and was kept clean and vermin free.
Site Preparation
The day prior to the first induction application, Site 1 of Group 1 animals was clipped free of hair on the upper left dorsal area with an electric clipper. The clipped area was approximately 5 x 5 cm. Any animal with skin irregularities or irritation was eliminated from the study. The treated sites were re-clipped the day prior to each induction application. Thirteen days after the last induction application, a naive site (Site 3) on the lower left dorsal area of each animal was clipped free of hair. Sites 2 and 4 (right upper and lower dorsal areas, respectively) were reserved for alternate sites in the event that severe irritation was noted during the induction phase and/or a re-challenge was required.
Dosing
Induction: Group 1, 100%: Ten males and 10 females were dosed with 0.4 g of the test article
(moistened with 0.1 ml of distilled water). The dose was applied to the left shoulder area (Site 1) using a 25-mm Hilltop Chamber® which is designed to keep the test article on a 25 mm area of the site. The chamber was covered with a strip of rubber dental dam sufficient to cover the treated sites. The torso was wrapped with non-irritating tape to provide occlusion. Six hours post-dosing, the dams and test article were removed. Any residual test article was cleansed from the sites with distilled water and the sites were dried with gauze or soft toweling. This procedure was performed once per week on the same day each week for a three week period, a total of three six-hour exposures.
Group 2: Five males and five females were untreated for the three-week induction period and
served as the naive control.
Challenge: Fourteen days after the last induction exposure, animals in Groups 1 and 2 were challenged using the same dosing procedure as in the induction phase. Based on the results of the induction application, 100% was chosen as the highest non-irritating concentration for the challenge. The doses were applied to a naive site on the lower left dorsal area (Site 3).
Type and Frequency of Observations
Skin reactions:
Induction - The treated sites of animals in Group 1 were examined and scored at 24 and 48 hours
following each patch removal for each induction period.
Challenge - The challenge sites of animals in Groups 1 and 2 were scored at 24 and 48 hours
following patch removal.
All reactions were evaluated according to the scoring code described below. Additional signs were described.
Skin Scoring Code
No reaction 0
Very faint erythema, usually non-confluent 0.5
Obvious faint erythema, usually confluent 1
Moderate erythema 2
Strong erythema, with or without edema 3
Animals were observed at least once daily for toxicity, pharmacologic effects and mortality. Observations included, but not be limited to, evaluation of skin and fur, eyes and mucous membranes, respiratory and circulatory effects, autonomic effects such as salivation, central nervous system effects including tremors and convulsions, changes in the level of activity, gait and posture, reactivity to handling or sensory stimuli, altered strength, and stereotypies or bizarre behavior (e.g., self-mutilation, walking backwards).
Body weights were recorded pre-test and at test termination.
All animals were humanely sacrificed using CO2 following test termination.
Analysis of Data
A score of 1 or greater at challenge in 15% or more of the animals is indicative of a sensitizing response.
To aid in the analysis of the data, two indices were calculated from the erythema scores: one to evaluate incidence and the other to evaluate severity. The indices were calculated for both the test article group and the naive control group using the 24 and 48-hour scores following challenge patch removal.
Incidence Index
The incidence index was calculated by counting the number of animals showing an erythema response (1 or greater) for a specified time period and dividing the number of test sites (animals) examined at that time period:
Incidence Index = No. of responses/No. per group
Severity Index
The severity index was calculated by adding the erythema scores for a specified time period and dividing the number of scores added:
Severity Index = Sum of erythema scores/No. of scores added
GHS Classification:
The test article was assigned to a category according to the current Globally Harmonized System (GHS) of Classification and Labeling of Chemicals. - Challenge controls:
- Group 2: Five males and five females were untreated for the three-week induction period and
served as the naive control. - Positive control substance(s):
- no
- Remarks:
- Group 2: Five males and five females were untreated for the three-week induction period and served as the naive control.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100% topical induction dose. Lithium nickel potassium oxide (KDLNO) at a concentration of 100%. The test article (0.4 g) moistened with 0.1 ml distilled water was applied dermally to a site.
- No. with + reactions:
- 7
- Total no. in group:
- 20
- Clinical observations:
- Clinical findings including, soiling, wetness and yellow staining of the anogenital area, brown staining on the abdomen and left hip area were observed.
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- Based on the topical induction dose of 100% (> 20%), lithium nickel potassium oxide (KDLNO) is considered to be a Category 1B dermal sensitizer according to GHS Classification and Labeling of Chemicals.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100% topical induction dose. Lithium nickel potassium oxide (KDLNO) at a concentration of 100%. The test article (0.4 g) moistened with 0.1 ml distilled water was applied dermally to a site.
- No. with + reactions:
- 3
- Total no. in group:
- 20
- Clinical observations:
- Clinical findings including, soiling, wetness and yellow staining of the anogenital area, brown staining on the abdomen and left hip area were observed.
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- Based on the topical induction dose of 100% (> 20%), lithium nickel potassium oxide (KDLNO) is considered to be a Category 1B dermal sensitizer according to GHS Classification and Labeling of Chemicals.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: Naive Control
- Dose level:
- Group 2 (five males and five females) was not induced and served as a naive control
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: Naive Control
- Dose level:
- Group 2 (five males and five females) was not induced and served as a naive control
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 1st reading
- Hours after challenge:
- 0
- Group:
- positive control
- Dose level:
- No positive control group in the study
- No. with + reactions:
- 0
- Total no. in group:
- 0
- Clinical observations:
- No positive control group in the study
- Reading:
- 1st reading
- Hours after challenge:
- 0
- Group:
- negative control
- Dose level:
- There was a naive control group in stead
- No. with + reactions:
- 0
- Total no. in group:
- 0
- Clinical observations:
- There was a naive control group in stead
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- The challenge sites of the test group with 100% topical induction dose had a score of one in 7 out of 20 animals (35%) at 24 hours and 3 out of 20 animals (15%) at 48 hours following patch removal, which is above 15%, the GHS criteria for skin sensitization. Based on the topical induction dose of 100% (> 20%), lithium nickel potassium oxide (KDLNO) is considered to be a Category 1B dermal sensitizer according to GHS Classification and Labeling of Chemicals.
- Executive summary:
The purpose of this study was to determine the potential of the test article, lithium nickel potassium oxide (KDLNO), to promote skin sensitization reactions after repeated applications. This study was designed to comply with the standards set forth in EPA Health Effects Test Guidelines, OCSPP 870.2600. OECD Guideline 406 is referenced in OCSPP 870.2600 as an acceptable method to assess the potential of a substance to promote skin sensitization reaction.
The challenge sites of the test group with 100% topical induction dose had a score of one in 7 out of 20 animals (35%) at 24 hours and 3 out of 20 animals (15%) at 48 hours following patch removal, which is above 15%, the GHS criteria for skin sensitization. Based on the topical induction dose of 100% (> 20%), lithium nickel potassium oxide (KDLNO) is considered to be a Category 1B dermal sensitizer according to GHS Classification and Labeling of Chemicals.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.